NASDAQ:OFIX - Orthofix Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $54.19 +0.12 (+0.22 %) (As of 09/23/2018 11:45 AM ET)Previous Close$54.19Today's Range$53.83 - $54.5052-Week Range$47.16 - $61.98Volume190,076 shsAverage Volume98,817 shsMarket Capitalization$1.02 billionP/E Ratio33.45Dividend YieldN/ABeta0.33 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas. Receive OFIX News and Ratings via Email Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical SymbolNASDAQ:OFIX CUSIPN6748L10 Webwww.orthofix.com Phone214-937-2000 Debt Debt-to-Equity RatioN/A Current Ratio3.71 Quick Ratio2.44 Price-To-Earnings Trailing P/E Ratio33.45 Forward P/E Ratio32.26 P/E Growth3.32 Sales & Book Value Annual Sales$433.82 million Price / Sales2.34 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)$1.62 Net Income$6.22 million Net Margins2.53% Return on Equity10.74% Return on Assets7.95% Miscellaneous Employees858 Outstanding Shares18,760,000Market Cap$1.02 billion Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions What is Orthofix Medical's stock symbol? Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX." How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Monday, August, 6th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.06. The medical device company earned $111.50 million during the quarter, compared to analysts' expectations of $114.62 million. Orthofix Medical had a net margin of 2.53% and a return on equity of 10.74%. The business's revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.42 EPS. View Orthofix Medical's Earnings History. When is Orthofix Medical's next earnings date? Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, October, 29th 2018. View Earnings Estimates for Orthofix Medical. What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical issued an update on its FY18 earnings guidance on Monday, August, 6th. The company provided earnings per share guidance of $1.66-1.72 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.65. The company issued revenue guidance of $450-456 million, compared to the consensus revenue estimate of $461.23 million.Orthofix Medical also updated its Q3 guidance to $0.35-0.79 EPS. What price target have analysts set for OFIX? 4 equities research analysts have issued 1 year price targets for Orthofix Medical's stock. Their predictions range from $56.00 to $67.00. On average, they expect Orthofix Medical's share price to reach $63.00 in the next year. This suggests a possible upside of 16.3% from the stock's current price. View Analyst Price Targets for Orthofix Medical. What is the consensus analysts' recommendation for Orthofix Medical? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical. Are investors shorting Orthofix Medical? Orthofix Medical saw a decrease in short interest in the month of August. As of August 31st, there was short interest totalling 477,585 shares, a decrease of 29.0% from the August 15th total of 672,614 shares. Based on an average daily volume of 147,133 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.6% of the company's stock are sold short. View Orthofix Medical's Current Options Chain. Who are some of Orthofix Medical's key competitors? Some companies that are related to Orthofix Medical include Cantel Medical (CMD), NuVasive (NUVA), Merit Medical Systems (MMSI), Tandem Diabetes Care (TNDM), Irhythm Technologies (IRTC), Glaukos (GKOS), Nevro (NVRO), Mazor Robotics (MZOR), Luminex (LMNX), Cryolife (CRY), AtriCure (ATRC), Cardiovascular Systems (CSII), Atrion (ATRI), K2M Group (KTWO) and Tactile Systems Technology (TCMD). Who are Orthofix Medical's key executives? Orthofix Medical's management team includes the folowing people: Mr. Bradley R. Mason, Pres, CEO & Director (Age 64)Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 52)Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 53)Mr. Michael M. Finegan, Chief Strategy Officer (Age 54)Mr. Davide Bianchi, Pres of Global Orthofix Extremities (Age 53) Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.74%), Dimensional Fund Advisors LP (4.72%), Renaissance Technologies LLC (3.61%), Segall Bryant & Hamill LLC (3.48%), Diamond Hill Capital Management Inc. (2.21%) and Acadian Asset Management LLC (1.89%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Luke T Faulstick, Raymond Fujikawa, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical. Which major investors are selling Orthofix Medical stock? OFIX stock was sold by a variety of institutional investors in the last quarter, including Oakview Capital Management L.P., Tygh Capital Management Inc., Bank of Montreal Can, Segall Bryant & Hamill LLC, GSA Capital Partners LLP, California Public Employees Retirement System, Wells Fargo & Company MN and BlueMountain Capital Management LLC. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi and Luke T Faulstick. View Insider Buying and Selling for Orthofix Medical. Which major investors are buying Orthofix Medical stock? OFIX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., First Trust Advisors LP, Paradice Investment Management LLC, Schwab Charles Investment Management Inc., Acadian Asset Management LLC, American Century Companies Inc., Renaissance Technologies LLC and Russell Investments Group Ltd.. View Insider Buying and Selling for Orthofix Medical. How do I buy shares of Orthofix Medical? Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Orthofix Medical's stock price today? One share of OFIX stock can currently be purchased for approximately $54.19. How big of a company is Orthofix Medical? Orthofix Medical has a market capitalization of $1.02 billion and generates $433.82 million in revenue each year. The medical device company earns $6.22 million in net income (profit) each year or $1.62 on an earnings per share basis. Orthofix Medical employs 858 workers across the globe. What is Orthofix Medical's official website? The official website for Orthofix Medical is http://www.orthofix.com. How can I contact Orthofix Medical? Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected] MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 280 (Vote Outperform)Underperform Votes: 319 (Vote Underperform)Total Votes: 599MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/23/2018 by MarketBeat.com StaffFeatured Article: Dividend Stocks - Are They Right For You?